Agilent s New Whole-Human-Genome Microarray Set for Commercial Release | GenomeWeb

Agilent Technologies on Tuesday announced the global commercial availability of its single-chip, whole-human-genome microarray product, and with it, announced a relaxation of volume purchase commitments for customers in the academic and non-profit sectors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.